1824-96-0

Basic information

• Product Name: .alpha.-D-Xylofuranoside, methyl
• Synonyms: .alpha.-D-Xylofuranoside, methyl;Methyl a-D-xylofuranoside;a-D-Xylofuranoside, Methyl;Methyl alpha-D-xylofuranoside
• CAS NO: 1824-96-0
• Molecular Formula: C₆H₁₂O₅
• Molecular Weight: 164.16
• Mol File: 1824-96-0.mol
• Article Data: 84

Chemical Properties

• Appearance: /
• Density: 1.40
• CAS DataBase Reference: .alpha.-D-Xylofuranoside, methyl(CAS DataBase Reference)
• NIST Chemistry Reference: .alpha.-D-Xylofuranoside, methyl(1824-96-0)
• EPA Substance Registry System: .alpha.-D-Xylofuranoside, methyl(1824-96-0)

Safety Data

• Hazardous Substances Data: 1824-96-0(Hazardous Substances Data)

Usage

General Description

.alpha.-D-Xylofuranoside, methyl, also known as methyl .alpha.-D-xylopyranoside, is a chemical compound derived from xylose, a type of sugar. It is a methylated form of xylose and is often used as a precursor in the synthesis of various pharmaceuticals and natural products. .alpha.-D-Xylofuranoside, methyl is commonly used in organic chemistry research, particularly in the study of carbohydrate structures and reactions. It has a molecular formula of C6H12O5 and a molecular weight of 164.16 g/mol. Methyl .alpha.-D-xylopyranoside is a white, crystalline solid that is soluble in water and organic solvents, making it a versatile compound for use in various chemical reactions.

Upstream product

• 67-56-1 methanol 
• 58-86-6 D-xylose 
• 532-20-7 D-Ribose 
• 2280-44-6 D-Glucose 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 37077-81-9 1,2-isopropylidene-α-D-ribofuranose 
• 2847-00-9 1,2:5,6-di-O-isopropylidene-α-D-hexofuran-3-ulose 
• 2595-05-3 Diacetone D-glucose 
• 4495-04-9 1,2-O-isopropylidene-α-D-allofuranose 
• 63846-98-0 1,2-O-(1-Methylethylidene)-α-D-ribo-pentodialdo-1,4-furanose 
• 5328-37-0 L-arabinose 
• 1114-34-7 D-lyxose 
• 609-06-3 L-xylose 
• 532-20-7 D-xylofuranose 

Downstream Products

• 2296-41-5 methyl-tri-O-methyl-arabinofuranoside 
• 86042-33-3 methyl 2,3,5-tri-O-p-toluyl-D-ribofuranoside 
• 108008-65-7 methyl 2,3,5-tri-O-(4-chlorobenzyl)-β-D-ribofuranoside 
• 83376-69-6 methyl 2,3-di-O-methyl-D-riboside 
• 83376-70-9 methyl 2,5-di-O-methyl-D-riboside 
• 83376-68-5 methyl 3,5-di-O-methyl-D-riboside 
• 2296-41-5 methyl 2,3,5-tri-O-methyl-D-ribofuranoside 
• 612-05-5 methyl-β-D-xylopyranoside 
• 91-09-8 methyl-α-D-xylopyranoside 
• 1824-97-1 methyl β-D-xylofuranoside 
• 80795-53-5 (2S,3R,4S,5R)-4-(benzyloxy)-5-((benzyloxy)methyl)-2-methoxytetrahydrofuran-3-ol 
• 885592-69-8 (2S,4R,5R)-4-(benzyloxy)-5-((benzyloxy)methyl)-2-methoxydihydrofuran-3(2H)-one 
• 948838-03-7 methyl 3,5-di-O-benzyl-2-C-β-methoxymethyl-α-D-ribofuranoside 
• 948838-08-2 methyl 2-O-benzoyl-3,5-di-O-benzyl-2-C-β-methoxymethyl-α-D-ribofuranoside 

Relevant articles and documents

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside. An oligomeric compound comprising a modified oligonucleotide consisting of 12-30 linked nucleosides, wherein at least one nucleoside of the modified oligonucleotide is a stereo-non-standard nucleoside; and wherein the oligomeric compound is selected from among an RNAi compound, a modified CRISPR compound, and an artificial mRNA compound.

BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION

The present disclosure provides biomarkers useful as companion diagnostics for detecting glycocalyx-based disease that is amenable to treatment using compounds designed for improving the condition of the glycocalyx and/or reducing inflammation and/or oxidative damage, as well as related compositions, kits, and methods.

Substituted pyrazole compound, preparation method, pharmaceutical composition and applications thereof

The invention discloses a substituted pyrazole compound represented by a formula I, and a preparation method, a pharmaceutical composition and applications thereof, wherein the compound has characteristics of good stability, excellent solubility, low cytotoxicity and remarkable neuroprotective effect, can effectively prevent and treat nerve cell injury, and is an ideal medicinal compound for preventing or treating cerebral stroke, cerebral embolism, cerebral stroke sequelae, cerebral stroke dyskinesia, mitochondrial encephalomyopathy and amyotrophic lateral sclerosis of spinal cord.